Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system

Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use has been met with many challenges. Portal Instrument...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: E. Lynne Kelley (VerfasserIn), Richard H. Smith (VerfasserIn), Gillian Corcoran (VerfasserIn), Sandra Nygren (VerfasserIn), Mary V. Jacoski (VerfasserIn), Andrea Fernandes (VerfasserIn)
Format: Buch
Veröffentlicht: Taylor & Francis Group, 2021-01-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use has been met with many challenges. Portal Instruments Inc. has been developing needle-free medication delivery using a well-designed hand-held device, PRIME, that is safe, intuitive to use, and utilizes advanced electronic control of a focused, high velocity, pressurized liquid injection stream. The PRECISE II human study demonstrated that the PRIME needle-free injection system was safe, well tolerated, and strongly preferred by participants for self-injections over a standard needle and syringe. In addition, the study was able to be completed early for superiority following the success of the pre-defined interim analysis.
Beschreibung:1071-7544
1521-0464
10.1080/10717544.2021.1976309